Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00600834 · ClinicalTrials.gov registry record
Evaluation of the Risk of NSF Following ProHance Injection in Patients With Chronic Kidney Disease
A clinical trial, sponsored by Bracco Diagnostics.
- Completed
- Registry status
- 172
- Enrollment target
NCT00600834 is a clinical trial that has completed, run by Bracco Diagnostics. The registered enrollment target is 172 participants.
The verdict
NCT00600834 has completed, sponsored by Bracco Diagnostics.
- COMPLETED
- Registry status
- 172 participants
- Enrollment target
Study Summary
The objective of this long term study is to prospectively compare the incidence of NSF in two cohorts (Cohort 1- patients with moderate chronic kidney disease eGFR 30-59 and Cohort 2- patients with severe chronic kidney disease or kidney failure eGFR \<30).
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 172 participants |
| Start Date | 2008-02 |
| Est. Completion | 2013-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00600834
The ClinicalTrials.gov registry entry for NCT00600834 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 172 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Bracco Diagnostics, which has 37 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00600834 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00600834 about?
NCT00600834 is a clinical study titled "Evaluation of the Risk of NSF Following ProHance Injection in Patients With Chronic Kidney Disease". The objective of this long term study is to prospectively compare the incidence of NSF in two cohorts (Cohort 1- patients with moderate chronic kidney disease eGFR 30-59 and Cohort 2- patients with severe chronic kidney disease or kidney failure eGFR \<30).
What is the current status of trial NCT00600834?
This trial is currently completed. The enrollment target is 172 participants. The study started on 2008-02. Estimated completion is 2013-05.
Who is sponsoring clinical trial NCT00600834?
This trial is sponsored by Bracco Diagnostics, which has 37 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.